Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariano Esteban

Showing results (71-80 of 256) with videos related to

Pageof 26
Sort By:
Viruses|April 9, 2015
The evolution of poxvirus vaccinesLucas Sánchez-Sampedro, Beatriz Perdiguero, Ernesto Mejías-Pérez, et al.
Journal of Virology|May 28, 2003
Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodesM Magdalena Gherardi, José Luis Nájera, Eva Pérez-Jiménez, et al.
Archivos Espanoles De Urologia|March 25, 2022
Statistical characterization of a good biomarker in oncologyLuis Mariano Esteban, María Etelvina Escorihuela-Sahún, Gerardo Sanz, et al.
Journal of Virology|September 13, 2003
Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cellsJuan Carlos Gallego-Gómez, Cristina Risco, Dolores Rodríguez, et al.
The Journal of General Virology|August 19, 2007
Virus distribution of the attenuated MVA and NYVAC poxvirus strains in miceCarmen Elena Gómez, José Luis Nájera, Elena Domingo-Gil, et al.
Viruses|August 12, 2018
Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene ExpressionMaría Q Marín, Patricia Pérez, Carmen E Gómez, et al.
The Journal of General Virology|October 1, 2013
New vaccinia virus promoter as a potential candidate for future vaccinesMauro Di Pilato, Ernesto Mejías-Pérez, Carmen Elena Gómez, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|April 26, 2019
Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysisOlivia Lafalla, Luis Mariano Esteban, Ana Cristina Lou, et al.
Virus Research|June 5, 2012
Vector replication and expression of HIV-1 antigens by the HIV/AIDS vaccine candidate MVA-B is not affected by HIV-1 protease inhibitorsJuan García-Arriaza, Pilar Arnáez, José Luis Jiménez, et al.
Carcinogenesis|March 10, 2007
Control of virus infection by tumour suppressorsCésar Muñoz-Fontela, María A García, Manuel Collado, et al.
Pageof 26

Showing results (71-80 of 256) with videos related to

Sort By:
Pageof 26
Viruses|April 9, 2015
The evolution of poxvirus vaccinesLucas Sánchez-Sampedro, Beatriz Perdiguero, Ernesto Mejías-Pérez, et al.
Journal of Virology|May 28, 2003
Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodesM Magdalena Gherardi, José Luis Nájera, Eva Pérez-Jiménez, et al.
Archivos Espanoles De Urologia|March 25, 2022
Statistical characterization of a good biomarker in oncologyLuis Mariano Esteban, María Etelvina Escorihuela-Sahún, Gerardo Sanz, et al.
Journal of Virology|September 13, 2003
Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cellsJuan Carlos Gallego-Gómez, Cristina Risco, Dolores Rodríguez, et al.
The Journal of General Virology|August 19, 2007
Virus distribution of the attenuated MVA and NYVAC poxvirus strains in miceCarmen Elena Gómez, José Luis Nájera, Elena Domingo-Gil, et al.
Viruses|August 12, 2018
Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene ExpressionMaría Q Marín, Patricia Pérez, Carmen E Gómez, et al.
The Journal of General Virology|October 1, 2013
New vaccinia virus promoter as a potential candidate for future vaccinesMauro Di Pilato, Ernesto Mejías-Pérez, Carmen Elena Gómez, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|April 26, 2019
Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysisOlivia Lafalla, Luis Mariano Esteban, Ana Cristina Lou, et al.
Virus Research|June 5, 2012
Vector replication and expression of HIV-1 antigens by the HIV/AIDS vaccine candidate MVA-B is not affected by HIV-1 protease inhibitorsJuan García-Arriaza, Pilar Arnáez, José Luis Jiménez, et al.
Carcinogenesis|March 10, 2007
Control of virus infection by tumour suppressorsCésar Muñoz-Fontela, María A García, Manuel Collado, et al.
Pageof 26